Real-time enrollment status for this ovarian cancer clinical trial
Current Status
Recruiting
Checked: October 18, 2026 at 11:53 AM UTC
| NCT Number | NCT07278336 |
| Recruiting Status | Recruiting |
| Condition | Ovarian Cancer |
| Phase | PHASE1 |
| Target Enrollment | 285 participants |
| Active Locations | 8 sites in the US |
| Sponsor | AbbVie |
| Last Updated on CT.gov | October 13, 2026 (5 days ago) |
As of October 18, 2026: Clinical trial NCT07278336 is currently recruiting participants. This phase1 study for ovarian cancer is actively seeking new participants at 8 locations across the United States. The study is sponsored by AbbVie. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07278336 is actively recruiting participants as of October 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07278336 was last updated 5 days ago (October 13, 2026). HelloStudys verifies this status automatically.